Stocks Flexing Their Muscles: Valero Energy Corporation (VLO), Teladoc Health, Inc. (TDOC)

Over the past 52 weeks, the shares of Valero Energy Corporation (NYSE:VLO) has been trading as low as $68.81 before witnessing a massive surge by 23.44% or $16.13. This price movement has led to the VLO stock receiving more attention and has become one to watch out for. It jumped by 0.85% on Thursday and this got the market excited. The stock’s beta now stands at 1.15 and when compared to its 200-day moving average and its 50-day moving average, VLO price stands -13.44% below and 3.93% above respectively. Its average daily volatility for this week is 2.3% which is more than the 1.94% recorded over the past month. The shares of Valero Energy Corporation dropped by -33.11% or -$42.04 from its last recorded high of $126.98 which it attained on April 06 to close at $84.94 per share.

Valero Energy Corporation (VLO) rose 5.4% this week, a trend that has led to both investors and traders taking note of the stock. Over the past one year, the equity price has embarked on a drop that has seen it decline -9.15% and is now up by 13.3% since start of this year. A look at its monthly performance shows that the stock has recorded a 3.17% gain over the past 30 days. Its equity price climbed by 15.93% over the past three months which led to its overall six-month decrease to stand at -26.2%.

Experts from research firms are bullish about the near-term performance of Valero Energy Corporation with most of them predicting a $107.06 price target on a short-term (12 months) basis. The average price target by the analysts will see a 26.04% rise in the stock and would lead to VLO’s market cap to surge to $45.18B. The stock has been rated an average 2.1, which roughly stands towards the bearish end of the spectrum. Reuters looked into the 20 analysts that track Valero Energy Corporation (NYSE:VLO) and find out that 5 of them rated it as a Hold. 15 of the 15 analysts rated it as a Buy or a Strong Buy while 0 advised investors to desist from buying the stock or sell it if they already possess it.

A look at VLO technical analysis shows that its 14-day Relative Strength Index (RSI) is in a neutral zone after reaching 58.42 point. Its trading volume has lost -915912 shares compared to readings over the past three months as it recently exchanged 3234088 shares. This means there is reduced activity from short-term traders as per session, its average trading volume is 4150000 shares, and this is 0.78 times the normal volume.

The price of Teladoc Health, Inc. (NYSE:TDOC) currently stands at $60.94 after it went up by $0.79 or 1.31% and has found a strong support at $59.79 a share. If the TDOC price drops below that critical support, then it would lead to a bearish trend. In the short-term, a dip below the $58.64 mark would also be bad for the stock as it means that the stock would plunge by 3.77% from its current position. However, if the stock price is able to trade above the resistance point around $61.75, then it could likely surge higher to try and break the upward resistance which stands at $62.56 a share. Its average daily volatility over the past one month stands at 4.1%. The stock has plunged by 84.49% from its 52-weeks high of $9.4501 which it reached on Jan. 10, 2018. In general, it is 37.4% above its 52-weeks lowest point which stands at $38.15 and this setback was observed on Feb. 04, 2018.

Analysts have predicted a price target for Teladoc Health, Inc. (TDOC) for 1 year and it stands at an average $81.19/share. This means that it would likely increase by 33.23% from its current position. The current price of the stock has been moving between $59.4501 and $61.41. Some brokerage firms have a lower target for the stock than the average, with one of them setting a price target as low as $67. On the other hand, one analyst is super bullish about the price, setting a target as high as $95.

The TDOC stock Stochastic Oscillator (%D) is at 13.74%, which means that it is currently oversold and its prices could jump very soon. The shares P/S ratio stands at 10.39 which compares to the 8.25 recorded by the industry or the 10.93 by the wider sector. The stock currently has an estimated price-earnings (P/E) multiple of 0, which is lower than the 0 multiple of 12-month price-earnings (P/E). The company’s earnings have gone up, with a quarterly increase rate of 28.8% over the past five years.

Analysts view Teladoc Health, Inc. (NYSE:TDOC) as a Buy, with 1.7 consensus rating. Reuters surveyed 18 analysts that follow TDOC and found that 2 of those analysts rated the stock as a Hold. The remaining 16 were divided, with 16 analyst rating it as a Buy or a Strong Buy while 0 analysts advised investors to desist from buying Teladoc Health, Inc. (TDOC) shares or sell it if they already own it.